14
total announcements
LASA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹25 Cr
EPS (TTM)
₹-0.80
52W Low
₹4.91
52W High
₹12.48
Dividend Yield
0.00%
Beta
0.64
Price / Book
0.5
Debt / Equity
19.6
Revenue (TTM)
₹7 Cr
Gross Margin
-53.20%
Operating Margin
-215.60%
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018. The company has received a certificate from Bigshare Services Private Limited, Registrar and Share Transfer Agent, for the quarter ended September 30, 2026.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 30, 2026, and informed the Exchange regarding voting results.
Lasa Supergenerics Limited
Lasa Supergenerics Limited held its 11th Annual General Meeting (AGM) on September 30, 2026, through video conferencing. The meeting was attended by 34 members, and the requisite quorum was present. The Chairman, Dr. Omkar Herlekar, addressed the members and provided an overview of the company's operations and financial performance for the financial year ended March 31, 2026. The meeting passed seven resolutions, including the adoption of annual accounts, appointment of a director, and approval of directors' remuneration.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange about General Updates, including the outcome of the Board Meeting held on September 09, 2026, where the Board approved the Notice of the 11th Annual General Meeting (AGM) to be held on September 30, 2026, and the re-appointment of Mr. Omkar Herlekar as a Director.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 09, 2026. The Board of Directors considered and approved several items, including the Notice of the Eleventh (11th) Annual General Meeting (AGM), the Director's Report, and the appointment of a new Director.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has been asked by the NSE to clarify its financial results for the quarter ended 30-Jun-2026 due to non-compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has appointed Mr. Janardan Savala as an Additional Director in the capacity of Executive Director, subject to approval from members at the ensuing General Meeting/Postal Ballot.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding the cessation of Mr. Ganesh as Executive Director of the company with effect from August 25, 2026.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted its integrated filing for the quarter ended June 30, 2026, including unaudited financial results and a limited review report from its statutory auditor. The company's factory in Ratnagiri suffered a fire incident in May 2025, resulting in significant damage and disruption to operations. The auditor's report highlights the exceptional item of uninsured loss due to the fire incident.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted its financial results for the period ended June 30, 2026.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has submitted its Structured Digital Database (SDD) compliance certificate for the quarter ended June 30, 2026, confirming the company's SDD is in place and meets all requirements.
Lasa Supergenerics Limited
Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.